Cross Country Healthcare (CCRN) Stock Price, News & Analysis

Company Overview

Cross Country Healthcare, Inc., headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.

The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs. Its travel nurse and allied health segment deploys registered nurses, licensed practical nurses, respiratory therapists and other allied health professionals to healthcare facilities on short-term assignments. Additionally, the permanent placement division supports client recruitment strategies by sourcing and placing full-time clinical personnel, while managed services programs streamline workforce management through customized staffing solutions and advanced technology platforms.

With operations spanning all 50 states, Cross Country Healthcare maintains an extensive network of clinical professionals and client partnerships across acute care hospitals, outpatient centers, rehabilitation facilities and long-term care settings. The company leverages proprietary data analytics and a centralized sourcing model to optimize workforce utilization, improve staff retention, and reduce operational costs for its healthcare provider clients.

Founded in 1999, Cross Country Healthcare has grown through organic expansion and strategic acquisitions to become one of the largest staffing providers in the healthcare industry. The company continues to invest in innovative staffing technologies and talent development initiatives to meet evolving workforce demands and enhance the quality of patient care nationwide.

Key Stats

• Today's Range: $13.25 to $13.25
• 50-Day Range: $13.17 to $13.25
• 52-Week Range: $7.43 to $14.99
• Volume: N/A
• Average Volume: 644,883 shs
• Market Capitalization: $428.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.05
• Consensus Rating: Reduce

Cross Country Healthcare Stock Analysis - MarketRank™

Cross Country Healthcare scored higher than 39% of companies evaluated by MarketBeat, and ranked 702nd out of 917 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Reduce

Consensus Rating

Cross Country Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.90, and is based on no strong buy ratings, no buy ratings, 9 hold ratings, and 1 sell rating.

Downside Risk

Cross Country Healthcare has a consensus price target of $12.05, representing about 9.1% downside from its current price of $13.25.

Amount of Analyst Coverage

Cross Country Healthcare has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 188.89%

Earnings Growth

Earnings for Cross Country Healthcare are expected to grow by 188.89% in the coming year, from $0.09 to $0.26 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cross Country Healthcare is -4.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cross Country Healthcare is -4.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Cross Country Healthcare has a PEG Ratio of 14.32. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Cross Country Healthcare has a P/B Ratio of 1.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.72% of the float of Cross Country Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Cross Country Healthcare has a short interest ratio ("days to cover") of 1.74, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cross Country Healthcare has recently decreased by 5.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cross Country Healthcare does not currently pay a dividend.

Dividend Growth

Cross Country Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cross Country Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.30% of the stock of Cross Country Healthcare is held by insiders.

Percentage Held by Institutions

96.03% of the stock of Cross Country Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/07/2026
• Today: 8/26/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:CCRN
• CIK: 1141103
• Web: www.crosscountryhealthcare.com
• Phone: (561) 998-2232
• Fax: 302-636-5454
• Employees: 6,784
• Year Founded: 1986

Price Target and Rating

• Average Price Target for Cross Country Healthcare: $12.05
• High Price Target: $14.00
• Low Price Target: $8.65
• Potential Upside/Downside: -9.1%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.90
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 147.22
• P/E Growth: 14.32
• Net Income: -$94.85 million
• Net Margins: -9.84%
• Pretax Margin: -8.62%
• Return on Equity: -0.74%
• Return on Assets: -0.54%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.29
• Quick Ratio: 3.29

Sales & Book Value

• Annual Sales: $1.00 billion
• Price / Sales: 0.43
• Cash Flow: $0.53 per share
• Price / Cash Flow: 25.11
• Book Value: $9.85 per share
• Price / Book: 1.35

Miscellaneous

• Outstanding Shares: 32,306,000
• Free Float: 30,271,000
• Market Cap: $428.05 million
• Optionable: Optionable
• Beta: 0.45